OncoXome, Inc. — Form D

OncoXome, Inc. of NORTH HOLLYWOOD, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-13. The offering totals $1.0M, of which $171K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2023-02-13
• Form: D
• Accession: 0001963883-23-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $1.0M
• Amount sold: $171K
• Remaining: $830K
• Investors: 2
• Date of first sale: 2022-12-02
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-473287

Issuer

• Name: OncoXome, Inc.
• CIK: 0001963883
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: 10824 BLOOMFIELD STREET, NORTH HOLLYWOOD, CA, 91602
• Phone: 805-444-7182

Officers, directors & promoters (6)

More

• CIK 1963883 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search